Approval · Notice of Compliance 22141 · 2019
TIBELLA: Notice of Compliance 22141
Issued May 10, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22141
- Date
- May 10, 2019
- Company
- BioSyent Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TIBELLA | 02488361 | Marketed |
Medicinal ingredients
- TIBOLONE 2.5 MG per TAB